Dr. Reddy's Laboratories Limited American Depositary Shares (RDY) is a publicly traded Healthcare sector company. As of September 4, 2026, RDY trades at $12.03 with a market cap of $10.14B and a P/E ratio of 0.00. RDY moved -1.15% today. Year to date, RDY is -13.20%; over the trailing twelve months it is -14.98%. Its 52-week range spans $11.36 to $16.17. Analyst consensus is buy with an average price target of $16.15. Rallies surfaces RDY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for RDY, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $12.03 |
| Market Cap | $10.14B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.11% |
| 52-Week High | $16.17 |
| 52-Week Low | $11.36 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
1 analysts cover RDY: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $16.15.